Suchergebnisse - "Church, Kevin J"

PubPharm (5)

1

Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2024

von Reda, S. | Setti, S. | Berthiaume, A. | +6

2

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2023

von Johnston, J. | Reda, S. | Setti, S. | +6

3

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

enthalten in: Neurotherapeutics | 2022

von Johnston, J. | Reda, S. | Setti, S. | +6

4

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

enthalten in: Neurotherapeutics | 2022

von Johnston, J. | Reda, S. | Setti, S. | +6

5

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia

enthalten in: NeuroRX | 2022

von Johnston, J. | Reda, S. | Setti, S. | +6

1
[1]